|
|
Volumn 16, Issue 1, 2015, Pages 21-23
|
|
More transparency for clinical trial data: The decision by the European Medicines Agency to make clinical trial reports publicly available could provide a boon for biomedical research
a
a
NONE
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
EUROPEAN MEDICINES AGENCY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFORMATION;
MEDICAL RESEARCH;
PATIENT CARE;
PRIORITY JOURNAL;
RARE DISEASE;
ACCESS TO INFORMATION;
ETHICS;
EUROPE;
LEGISLATION AND JURISPRUDENCE;
MEDICAL RECORD;
PUBLICATION;
UNITED STATES;
ACCESS TO INFORMATION;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
EUROPE;
HEALTH RECORDS, PERSONAL;
HUMANS;
PUBLICATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84924972521
PISSN: 1469221X
EISSN: 14693178
Source Type: Journal
DOI: 10.15252/embr.201439894 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
